Article
Mechanism of Sanliangsan Lipid-Lowering in treating hyperlipidemia: insights from network pharmacology and molecular docking
2025-09-28
Abstract excerpt
Abstract Background and Objective This study used network pharmacology to identify active ingredients, key targets, and signaling pathways of Sanliangsan Lipid-Lowering (SLL) for hyperlipidemia (HLP), and clarify its lipid-lowering material basis and mechanism. Methods SLL active ingredients were retrieved from TCMSP, with corresponding targets obtained from Uniprot (duplicates excluded). Cytoscape co...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 9c97d332-ebef-5e02-ac46-8120fd65797e
- DOI
- 10.1101/2025.09.25.678651
